Search clinical trials for: Dabrafenib Mesylate
Total 1801 results
-
Eisai LimitedCompleted
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
National Human Genome Research Institute (NHGRI)CompletedBRAF V600E MutationUnited States
-
National Cancer Institute (NCI)WithdrawnDabrafenib and Trametinib in Treating Patients With Erdheim Chester Disease With BRAF V600 MutationsErdheim-Chester DiseaseUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingLocally Advanced Melanoma | Unresectable Melanoma | Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 | Clinical Stage IV Cutaneous Melanoma AJCC v8 | Pathologic Stage IV Cutaneous Melanoma AJCC v8United States
-
University of BolognaCompletedMyeloid Leukemia, Chronic, Chronic-PhaseItaly
-
Chengdu Zenitar Biomedical Technology Co., LtdCompletedDiffuse Large B Cell Lymphoma，DLBCLChina
-
Novartis PharmaceuticalsTerminated
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedRefractory Desmoplastic Small Round Cell TumorsItaly
-
Universitair Ziekenhuis BrusselCompleted
-
UNC Lineberger Comprehensive Cancer CenterGlaxoSmithKlineCompletedUnresectable Melanoma | Stage IV Melanoma | Stage III Melanoma | BRAF Mutant MelanomaUnited States
-
Novartis PharmaceuticalsCompletedMalignant MelanomaPortugal
-
Spirita Oncology, LLCUniversity of ArizonaTerminatedBrain Metastases | Malignant MelanomaUnited States
-
Fondazione Melanoma OnlusWithdrawn
-
University Medical Center GroningenTerminated
-
GlaxoSmithKlineCompleted
-
IlDong Pharmaceutical Co LtdCompletedHealthyKorea, Republic of
-
Sun Yat-sen UniversityNot yet recruitingNSCLC | BRAF V600 Mutation | MET Exon 14 MutationChina
-
Novartis PharmaceuticalsRecruiting
-
Novartis PharmaceuticalsRecruiting
-
Leiden University Medical CenterNovartisRecruitingAnaplastic Thyroid CancerNetherlands
-
Novartis PharmaceuticalsRecruitingBRAF V600E Mutation-positive Unresectable Advanced or Recurrent Solid TumorJapan
-
Pediatric Brain Tumor ConsortiumNational Cancer Institute (NCI); American Lebanese Syrian Associated Charities...RecruitingLow Grade Glioma (LGG) of Brain With BRAF Aberration | High Grade Glioma (HGG) of the Brain With BRAF Aberration | Low Grade Glioma of Brain With Neurofibromatosis Type 1United States
-
Novartis PharmaceuticalsRecruitingGlioblastoma | Astrocytoma | Anaplastic Astrocytoma | Neurofibromatosis Type 1 | Anaplastic Ganglioglioma | Anaplastic Pleomorphic Xanthoastrocytoma | Ganglioglioma | Pleomorphic Xanthoastrocytoma | Diffuse Astrocytoma | Anaplastic Oligodendroglioma | Pilocytic Astrocytoma | Gangliocytoma | Central Neurocytoma | Oligodendroglioma... and other conditionsUnited States, Belgium, Spain, Denmark, Germany, Czechia, Italy, Australia, Russian Federation, France, Brazil, Netherlands, Japan, Canada, Finland, Sweden, United Kingdom, Argentina, Israel
-
Novartis PharmaceuticalsAvailable
-
Novartis PharmaceuticalsRecruitingMelanoma | Solid Tumor | High Grade Glioma | Non Small Cell Lung Cancer | Rare CancersSpain, Germany, United States, Argentina, Austria, Denmark, France, Hungary, Netherlands, China, Japan, Thailand
-
Novartis PharmaceuticalsAvailable
-
Poitiers University HospitalCompletedUnresecable Stage IIIc or IV MelanomaFrance
-
Saint Petersburg State University, RussiaRecruitingAnaplastic Thyroid CancerRussian Federation
-
Eva Marie Erfurth, MD, PhDNovartisRecruiting
-
EuMelaReg gGmbHActive, not recruiting
-
Haukeland University HospitalBerGenBio ASAActive, not recruiting
-
GlaxoSmithKlineTerminatedMelanoma and Brain MetastasesUnited States, Australia
-
Melanoma and Skin Cancer Trials LimitedMelanoma Institute AustraliaCompleted
-
Novartis PharmaceuticalsRecruitingDifferentiated Thyroid CancerChina, Korea, Republic of, Taiwan, India, Malaysia, Turkey, Canada, Vietnam, Argentina, Brazil, Mexico, United States
-
National University Hospital, SingaporeSingapore General HospitalUnknown
-
University of UtahTerminatedStage III or IV MelanomaUnited States
-
Eisai Inc.Completed
-
Eisai Co., Ltd.Completed
-
Calgent Biotechnology Co., LtdCompletedResistant or Refractory Solid TumorsUnited States, Taiwan
-
Eisai Korea Inc.CompletedBreast Cancer | Breast NeoplasmsKorea, Republic of
-
Eisai Inc.Approved for marketingMetastatic Breast CancerCanada, Belgium, France
-
Merz Pharmaceuticals GmbHTerminatedSubjective TinnitusUnited States, United Kingdom, Poland, Austria, Belgium, Brazil, Czech Republic, France, Germany, Mexico, Netherlands, Portugal, South Africa, Spain
-
Pathway Therapeutics, Inc.Completed
-
Merz Pharmaceuticals GmbHTerminatedMultiple Sclerosis | Nystagmus, Congenital | Nystagmus, AcquiredUnited Kingdom
-
Merz Pharmaceuticals GmbHCompleted
-
Nanjing First Hospital, Nanjing Medical UniversityEnrolling by invitationMain Heading (Descriptor) TermsChina
-
Eisai LimitedCompletedAdvanced Solid TumorFrance
-
Zhejiang Cancer HospitalNot yet recruitingAdvanced Colorectal CancerChina